Mesoblast Competitors and Similar CompaniesClear all

Mesoblast's competitors and similar companies include Celltex, Lophius Biosciences, Harmony Biosciences and Phoenix Nest.

	Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.	Celltex Celltex Therapeutics is a biotechnology company that provides stem cell banking and therapy services.	Lophius Biosciences Lophius Biosciences is a biotechnology company developing products for the diagnosis of acute infectious and autoimmune diseases.	Harmony Biosciences Harmony Biosciences develops therapies to help patients with unmet medical needs.	Phoenix Nest Phoenix Nest is a biotech company that provides treatment for the disease Sanfilippo syndrome.
Founding Date	Founding Date 2004	Founding Date 2011	Founding Date 2002	Founding Date 2017	Founding Date 2012
Type	Type Public	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech medical diagnostics therapy	Tags Healthcare biotech therapy	Tags Healthcare biotech medical diagnostics therapy	Tags Healthcare biotech medical diagnostics therapy	Tags Healthcare biotech medical diagnostics therapy
Locations	Locations Melbourne, AU HQ Singapore, SG New York, US	Locations Houston, US HQ	Locations Regensburg, DE HQ	Locations Plymouth Meeting, US HQ	Locations New York, US HQ
Employees	Employees 73	Employees 313% increase	Employees 2	Employees N/A	Employees 10
Valuation ($)	Valuation ($) 1.2 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $17.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $868.5m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $1.2m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $198.3m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $16.1m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $670.1m (FY, 2025)	Gross profit N/A
Net income	Net income ($102.1m) (FY, 2025)	Net income N/A	Net income N/A	Net income $158.7m (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 34.1m (almost 14 years ago)	Latest funding round $ 2.4m (about 9 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 56.2m	Total funding raised $ 34.1m	Total funding raised $ 14.4m	Total funding raised $ 270m	Total funding raised N/A